98 studies found for:    Open Studies | "Anticoagulants"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
2 Recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
3 Not yet recruiting Anticoagulant Safety at Hospital Discharge
Condition: Anticoagulants
Intervention: Other: Anticoagulation Coordinated Care
4 Recruiting Per-procedural Concentration of Direct Oral Anticoagulants
Condition: Per-procedural Concentrations of Oral Anticoagulants
Intervention: Other: DOAC concentration measurement
5 Unknown  Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events
Conditions: Incidence of Readmissions;   ADE's Due to Anticoagulants
Intervention:
6 Recruiting Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.
Conditions: Aortic Valve Disease;   Heart Valve Prosthesis Implantation;   Anticoagulants
Intervention: Drug: Rivaroxaban
7 Recruiting Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE
Conditions: Elderly;   Pulmonary Embolism;   Anticoagulants
Intervention: Other: 4 blood samples
8 Recruiting Perioperative Anticoagulant Use for Surgery Evaluation Study
Condition: Atrial Fibrillation
Intervention:
9 Unknown  Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
10 Recruiting Novel Oral Anticoagulants in Stroke Patients
Conditions: Ischemic Stroke,;   Intracranial Hemorrhage,
Intervention:
11 Recruiting Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
Condition: Atrial Fibrillation and Flutter
Intervention: Other: New oral anticoagulant pharmacodynamic analysis (blood level assesment)
12 Not yet recruiting Safety of Oral Anticoagulants Registry
Condition: Blood Coagulation
Intervention: Other: mgt of bleeding concerns/complications of oral anticoagulants
13 Not yet recruiting Pleotropic Effect of New Oral Anticoagulants
Condition: Atrial Fibrillation
Interventions: Drug: dabigatran;   Drug: ribaroxaban;   Drug: Warfarin
14 Recruiting Therapy With New Oral Anticoagulants
Conditions: Atrial Fibrillation;   Non-valvular Atrial Fibrillation
Intervention:
15 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
16 Recruiting Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime
Conditions: Ischemic Stroke;   Intracerebral Hemorrhage;   Oral Anticoagulation;   Cardiovascular Diseases;   Vascular Diseases
Intervention: Other: not applicable (observational study)
17 Recruiting New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study
Condition: Atrial Fibrillation
Intervention: Other: Plasma drug concentrations
18 Unknown  Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
19 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
20 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years